NIBSC - 17th SoGAT Meeting

Enter a search term

Home Page > Spotlight > Standardisation of Genome Amplification Techniques > Blood virology > Past meetings > 17th SoGAT Meeting

17th SoGAT Meeting

Return to previous page|

May 2

Speaker	Affiliation	Presentation
Adrian Bristow, NIBSC	National Institute for Biological Standards and Control	View Presentation
Clare Davis,NIBSC	Evaluation of Candidate Standard XX (97/650)	View Presentation
Matthias Gessner, Plasma Control/Plasma Analytics Baxter, Austria	Parvovirus B19: Assays, Limits and the Outcome	View Presentation
Piotr Grabarczyk, Institute of Haematology Blood Transfusion, Warsaw	Current status of NAT in Poland	View Presentation
Lutz Pichl, German Red Cross Blood Transfusion Centre West, Hagen	Magnetic bead technology in viral RNA/DNA extraction from plasma minipools	View Presentation
Giulio Pisani, Istituto Superiore di Sanità, Italy	Italian EQA study for HCV RNA, HIV RNA and HBV DNA	View Presentation
W. Kurt Roth, Red Cross Blood Transfusion Service Baden-Württemberg	B19 Overview of Testing for Blood Banks	View Presentation
Morag Ferguson, NIBSC	CE MARKING OF IVDDs - the NIBSC perspective	View Presentation
Sally Baylis, NIBSC	Testing for Parvovirus B19 - Broadening the Assay to Cover Variants	View Presentation
Perrine Caillet-Fauque, Université Libre de Bruxelles	B19 production in hepatocarcinoma cells and neutralization	View Presentation
H.-P. Grunert	The Impact of International Standard Materials on Correct Test Results: Experiences from EQASs for HIV, HCV, HBV and BSE	View Presentation
Indira Hewlett, CBER/FDA	An Overall View of Standardization	View Presentation
Harvey Holmes, NIBSC	SoGAT and the Development of Standards	View Presentation
Vivienne James, UKNEQAS	Surveillance and Screening of Blood Borne Pathogens	View Presentation
Frank Krieg-Schneider Strategic Alliances, QIAGEN	Standardization of Sample Preparation for NAT	View Presentation
Mei-ying W Yu, CBER/FDA	B19 Testing of Plasma for Fractionation: Current Thinking	View Presentation
Mark Manak, Boston Biomedica, Inc.	Controls for Human Papilloma Virus (HPV) DNA testing	View Presentation
Bruce H. Phelps Chiron Corporation	History of ILC Involvement in NAT Standardization	View Presentation
Cécile El Hana NIBSC	Investigation of the efficacy of novel pathogen removal/inactivation methods for plasma pools	View Presentation
K. Furuya Japanese Red Cross Plasma Fractionation Center	Analysis of human parvovirus B19 components and strategies of non-enveloped virus removal from factor VIII concentrates	View Presentation
Bayer Molecular Bayer	Customer HIV-1 Quantitation QA Scheme	View Presentation
Harry van Drimmelen VQC-Sanquin	Sensitivity of NAT blood screening assays in performance evaluation and proficiency programs	View Presentation
Michael Chudy Paul-Ehrlich-Institut	Proficiency Testing of In-House Developed HIV-1 NAT for Blood Screening	View Presentation
Dr. Hwei-Fang Cheng Department of Health, Taiwan	Preparation of HBV DNA reference standards and the experience of HBV NAT in Taiwan	View Presentation
Micha Nübling PEI	CE mark issues - PEI View	View Presentation
David Wood WHO	WHO and Transplantation	View Presentation
John Saldanha Canadian Blood Services	NAT Detection of Blood Borne Viral Markers in Tissues from Cadaver Donors	View Presentation
Bill Casley Centre for Biologics Research	The Canadian Experience with WNV Testing	View Presentation
Jean Gabert ERT MEIDIA & APHM, France	Reference reagents for monitoring minimal residual disease	View Presentation
Christoph Niederhauser Blood Transfusion Service SRC Berne, Switzerland	Organisation and Experience with HCV-PCR in Switzerland	View Presentation
D Candotti, N Etiz, A Parsyan, JP Allain	Persistent human erythrovirus infection in blood donors	View Presentation

17th SoGAT Meeting

May 2

Speaker

Affiliation

Presentation